Sanjay Kumar Mohanty

• Successfully launched Amneal Oncology in Odisha, Patna, and Visakhapatnam.
• Successfully launched major focus brands of Amneal, i.e. Abiraneal, Enzaneal, Reluvxy Goparib, and 5 Global Innovator brands of Novartis: Spexib, Pivikto, Refinlar, and Votrient.
• Converted Top 15 KOLs for Amneal Oncology.
• I got an increment for 2024 as a best performer.
• Achieved more than 100% for the Amneal Portfolio and 263% for the Novartis Portfolio for the year 2025.
• Conducted 15 scientific speaker meetings consecutively, 2 physical CME with top KOLs, and participated in more than 5 national and regional cancer conferences.
• Conducted regular account reviews with clients to assess performance, identify areas for improvement, and strategize future growth opportunities.
• Analyzed sales and customer data to identify trends and opportunities for increased profitability.

Key Brands Handling -

• Goparib and Bevaneal - Ovarian Cancer.
• Trastuneal and Paclineal Nab-Breast Cancer.
• Abiraneal, Enzaneal, & Reluvxy - Prostate Cancer
• Romineal & Amferro-Hematological Malignancies.
• Refinlar & Meqsel - BRAF-mutated melanoma, advanced lung cancer, and anaplastic thyroid cancer.
• Pivikto - HR+ HER2- PIK3CA mutated Advanced/Metastatic Breast Cancer

• Key Accounts Management
• Distributor Handling
• Products Launch
• Conducting scientific activity
• Partipating in National & Regional conferences
• Key Brands Handling-Biosimilars Pruinta(Trastuzumab ),Bevacizab(Bevacizumab) & Hermoclib(Palbociclib)
• Set and achieved company defined sales goals.
• Fostered lasting relationships with customers through effective communication and quick response, resulting in long-term loyalty and expanded client base.

• Key Accounts Management
• Distributor Handling
• Products Launch
• Conducting scientific activity
• Partipating in National & Regional conferences
• Set and achieved company defined sales goals.
• Fostered lasting relationships with customers through effective communication and quick response, resulting in long-term loyalty and an expanded client base.

Key Brands Handling -

Hertraz (Trastuzumab),Teceris(Eribulin) & Nabtoxol - Breast Cancer

Abevmy (Bevacizumab) - Ovarian, Lung, GBM, CRC.

Dasamyl(Dasatinib)/Bosutris(Bosutinib)-CML(Hematology)

Degalyn & Mytera-Prostate Cancer

• Key Accounts Management
• Distributor Handling
• Products Launch
• Conducting scientific activity
• Partipating in National & Regional conferences

Key Brands Handling -

Cizumab-Ovarian/CRC/GBM/LUNG

MABALL-NHL/CLL-Hematology

MOZIFOR (Plerixafor) - BMT in NHL and Multiple Myeloma.

PEG-L - ASPATERO - ALL

• Key Accounts Management
• Distributor Handling
• Products Launch
• Conducting scientific activity
• Partipating in National & Regional conferences

• Distributor Handling
• Brands Promotion
• Conducting scientific activity

• Distributor Handling
• Brands Promotion
• Conducting scientific activity